Your email has been successfully added to our mailing list.

×
0 0 0.0113636363636363 0 0.00313636363636359 0.0113636363636363 0.0113636363636363 0.00568181818181806
Stock impact report

Immune Design Announces Launch of Web Portal for SYNOVATE Phase 3 Study of CMB305 Immunotherapy in Synovial Sarcoma

IMMUNE DESIGN CORP COMMON STOCK (IMDZ) 
Last immune design corp common stock earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.immunedesign.com/investor-relations
Company Research Source: GlobeNewswire
          -- 1st global Phase 3 trial focused on synovial sarcoma patients SYNOVATE is a randomized, global Phase 3 trial to evaluate CMB305 immuontherapy in synovial sarcoma patients. www.synovatestudy.com           -- www.synovatestudy.com SEATTLE and SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on novel therapies in oncology, today announced the launch of the patient and healthcare provider websites for the SYNOVATE study – a pivotal trial to evaluate CMB305 immunotherapy in synovial sarcoma patients. Clinical sites will soon be open for enrollment initially in the US, with information available at www.synovatestudy.com. “Patients with advanced synovial sarcoma often have few systemic treatment options immedia Show less Read more
Impact Snapshot
Event Time:
IMDZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMDZ alerts
Opt-in for
IMDZ alerts

from News Quantified
Opt-in for
IMDZ alerts

from News Quantified